Skip to main content

Table 1 Baseline demographics and ocular characteristics

From: Diabetic macular edema treated with intravitreal aflibercept injection after treatment with other anti-VEGF agents (SWAP-TWO study): 6-month interim analysis

Demographics

Baseline

 Eyesa (right:left)

20 (11:9)

 Average age at screening

63.7 (45–78)

 Gender (female:male)

13:7

 Average prior injectionsb

4.25

ETDRS scores: average (range)

 Study eye

69.95 (60–81)

 Fellow eye

73.65 (37–85)

Diabetic retinopathy severity

 Mild

0

 Moderate

9

 Severe

5

 PDR

6

OCT values

 Study eye

  CST [Mean (range)]

419.7 (328–585)

  Cube volume [Mean (range)]

11.55 (9.1–13.9)

  Cube average thickness [Mean (range)]

320.7 (253–386)

 Fellow eye

  CST [Mean (range)]

300.40 (181–432)

  Cube volume [Mean (range)]

10.81 (8.8–12.8)

  Cube average thickness [Mean (range)]

300.20 (246–354)

  1. aOnly one eye per patient, bon the 6 month prior enrollment
  2. CST central subfield thickness, ETDRS early treatment diabetic retinopathy study, OCT optical coherence tomography